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ABSTRACT
Background:In the past, the use of intrauterine contraceptive device (IUCD), in particular, Dalkon Shield was found to be 
associated with increased risk of pelvic infection. Recent literature illustrates that the risk of pelvic infection after insertion 
of an IUCD is low and that the risk peaks in the 1st month after insertion. We set out to determine the incidence of genital 
infection among IUCD users after the 1st and 3rd months of insertion compared to users of other contraceptive methods; to 
determine the risk of genital infections among IUCD users compared to users of other contraceptive methods and to determine 
the organisms associated with genital infection among the contraceptive users.
Materials and Methods: This was a cohort study involving new clients who chose various forms of contraceptives.
Results: The incidence of genital infection was 3 (8.5%) at 1 month and 4 (12.1%) at 3 months. The incidence in non‑IUCD 
contraceptive users was 2 (5.9%) at 1 month and 3 (8.8%) at 3 months. The relative risk was 1.44 and 1.5 at 1 and 3 months, 
respectively. The observed difference in the rate of infection between IUCD users and other contraceptive users was not 
statistically significant. Bacteria vaginosis and Trichomonas vaginalis were commonly observed in the two groups.
Conclusion: The incidence of genital infection among IUCD users was relatively low compared to non-IUCD users. IUCD s 
do not significantly increase the of rate genital infection.
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Introduction
The intrauterine contraceptive device (IUCD) is one of the 
most widely used long-acting contraceptive methods.[1-3] It 
offers effective protection from pregnancy and is effective 
for long-term use. The device can be inserted at anytime as 
long as pregnancy has been ruled out.[4,5] It is estimated that 
there are about 180 million users worldwide, with over 80% 
of these residing in Asia.[6] In Nigeria, the acceptance rate 
for IUCD ranges from 47% to 66% in different family planning 
centres.[3,5,7] Different studies have been conducted to explore 
the IUCD-related diseases particularly those associated with 
infection. Some studies linked the infection-related diseases 
to the insertion method and technique. This is because the 
postinsertion pelvic infection is generally low but appears to 
be highest in the first 3 weeks’ postplacement.[8,9] Despite the 
overall low risk documented in various places, it is prudent 
to determine the risk in the northwest subregion of Nigeria.
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We set out to determine the incidence of genital infection 
among IUCD users after the 1st and 3rd months of insertion 
compared to users of other contraceptive methods during the 
same period; to compare the incidence of common organisms 
isolated in the two groups and also to determine the risk of 




The study was conducted at the two Family Planning clinics of 
the Usmanu Danfodiyo University Teaching Hospital, Sokoto.
Study design
This was a Cohort study.
Sample determination
The sample size of 35 in each group was obtained using the 
formula for group comparison and considering 10% attrition rate.
Study population
This includes women who presented to the family planning 
clinic for new method of contraception. Thirty-five new 
clients who chose IUCD and another 35 new clients who 
chose other forms of contraceptives and had no genital 
infection were recruited.
Sampling method
The patient who met the inclusion criteria were enrolled 
consecutively.
Inclusion criteria
Clients that chose IUCD for contraception and gave consent 
for the study were included as cohorts while those that chose 
other forms of contraceptives served as controls.
Exclusion criteria
Women with genital infections and contraindications to IUCD 
insertion such as gynecological cancers, pelvic inflammatory 
disease (PID), and pregnancy were excluded from the study.
Sampling method
The women were screened for genital infection, and eligible 
clients were recruited by convenience sampling method. 
A semi-structured questionnaire was used to obtain relevant 
information, and all clients were recruited from September 
2015 to November 2015 and followed for 3 months.
Sample collection
Before insertion of the IUCD, clients in whom microbes 
were isolated from their vaginal and/or cervical swabs were 
excluded from the study. An endocervical specimen was 
collected for culture using a sterile cotton swab during 
vaginal examination to detect Neisseria gonorrhoeae, after 
inoculation into Thayer Martin and 5% blood agar. Thereafter, 
the endocervical swab was used to make smear to detect 
Chlamydia trachomatis inclusion body. Two different high 
vaginal swabs were taken to isolate for Trichomonas vaginalis, 
Candida species, Gardnerella vaginalis, and anaerobes. One of 
the high vaginal swabs was used to make wet mount and 
Gram staining, while the second swab was used for culture.
Three drops of physiological saline were added and mixed 
with the first high vaginal swab. A drop of the sample 
collected was transferred to a microscope slide, covered 
with a cover slide, labeled, and then delivered to the 
laboratory for immediate examination. A drop from the 
same sample was also transferred to another microscope 
slide and spread to make a thin smear. It was then allowed 
to air dry, labeled and transferred to the laboratory for Gram 
staining. The sample from the second swab was inoculated 
into MacConkey agar and 5% sheep blood agar. The cervix, 
vagina, and vulva were then cleaned with antiseptic solution. 
The IUCD was then inserted using “no touch technique” by 
the researcher. The same procedure was done for clients that 
chose other contraceptive methods. The endocervical and 
vaginal sampling were then repeated after 1 month and after 
3 months by the investigators.
Specimen transport
The swab sticks had Amies medium which served as transport 
medium used for the transport of samples to the laboratory. 
Samples were also analyzed within 2 h of collection.
Study procedures
Wet saline preparation
This was carried out to detect T. vaginalis trophozoites, motile 
bacteria, Candida species, epithelial cells, and pus cells. The 
high vaginal swab was utilized to make the preparation. 
The preparation was examined using a microscope with the 
10 × and 40 × magnification objectives. Trophozoites of 
T. vaginalis may measure about 10–20 µm, and they are round 
or oval and move by an aid of undulating membrane and four 
anterior flagella while the fifth flagellum forms an undulating 
membrane. These features were checked.
Direct Gram smear
The high vaginal swab was gently rolled onto a glass slide. 
The smear was allowed to air dry then fixed with methanol 
and stained by Gram’s technique. Using the 40 × and 
100× (oil immersion) objectives, the smear was examined 
for pus cells and bacteria. Pus cells containing Gram-negative 
diplococci denote N. gonorrhoeae. Large Gram-positive yeast 
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cells and pseudohyphae could be Candida species. In bacterial 
vaginosis, epithelial cells with adhering Gram-negative 
short bacilli and Gram-variable coccobacilli (G. vaginalis, 
Mobiluncus, or Anaerobes) may be visualized. The margin 
of the epithelial cells is often obscured (clue cells) by the 
adhering bacteria.
Giemsa staining for chlamydial inclusion body
The endocervical swab was used to make a smear on a glass 
slide. The smear was allowed to air dry, fixed and then stained 
with Giemsa stain. Chlamydial infection was suspected when 
blue-mauve colored inclusion bodies were seen in epithelial 
cells.
Culture and colonial morphology
The high vaginal swab was inoculated on two plates of 5% 
Sheep Blood agar and one plate of MacConkey agar. The 
MacConkey agar plate was incubated aerobically at 37°C 
for 18–24 h. The first plate of 5% Sheep Blood agar was 
incubated aerobically at 37°C for 18–24 h for aerobes and 
facultative organisms. The second plate of 5% Sheep Blood 
agar was incubated anaerobically in an anaerobic jar looking 
for obligate anaerobes.
Staphylococcus aureus produces yellow-cream colored colonies 
that are 1–2 mm in diameter and they are beta hemolytic on 
5% Sheep blood agar. On MacConkey agar, the Staphylococcus 
colonies appear pinkish signifying lactose fermentation. 
Streptococcus agalactiae produce grey mucoid colonies about 
2 mm in diameter surrounded by a beta hemolytic zone 
on Blood agar. Escherichia coli produce 1–4 mm in diameter 
colonies that appear pinkish signifying lactose fermentation. 
They are slightly mucoid and beta hemolytic on 5% Sheep 
blood agar. Candida albicans produces pale, creamy colored, 
pasty colonies on blood agar with a distinctive yeasty smell. 
Actinomyces israeli produces small creamy white colonies with 
a rough nodular surface that glistens on 5% sheep blood agar 
following anaerobic incubation.
The endocervical swab was inoculated in Thayer Martins 
medium looking for N. gonorrhoeae. The Thayer Martins 
medium was incubated in a moist carbon dioxide enriched 
atmosphere at 35°C–37°C for 18–24 h. This was then examined 
for growth after overnight incubation. N. gonorrhoeae 
produces small raised, gray shiny colonies.
Motility testing
E. coli is motile by means of peritrichous flagella. The motility 
test was demonstrated by using a fresh culture of suspected 
colonies of E. coli grown on MaConkey agar plate after 
inoculation in normal saline then transferred to a hanging 
drop slide. This was viewed using the 10 × objective.
Biochemical test
Oxidase and Sugar fermentation test was performed on 
suspected N. gonorrhoeae colonies. N. gonorrhoeae colonies 
are oxidase positive and ferment glucose but not lactose, 
maltose, or sucrose.
Catalase and coagulase test was employed to differentiate 
between the Gram-positive cocci. S. aureus is catalase and 
coagulase positive while S. agalactiae is catalase negative.
Candida species was further confirmed to their specie level 
by the use of Germ tube test and sugar assimilation test. C. 
albicans is germ tube positive, while other species are negative.
Data analysis
The results obtained were analyzed using Statistical Package 
for Social Sciences (SPSS) version 21.0 (Armonk, NY, IBM Corp). 
Data were presented using tables and Figures. Categorical 
data such as occupation of respondents were summarized 
using frequencies and percentages. Chi-square test was used 
to compare associations. P <0.05 was considered statistically 
significant.
Ethical consideration
Ethical clearance was obtained from the Ethics and Research 
Committee of the University Teaching Hospital. Informed 
consent was also obtained from the respondents before data 
collection. Patients with infection were treated and their 
spouses and co-wives were referred to appropriate clinics.
Limitations
• The clients were followed‑up for only 3 months; 
therefore, a long-term effect of IUCD could not be 
determined
• The effect of other copper‑containing IUCDs other than 
copper T-380A could not be assessed as they are not 
commonly used in the study area.
Results
A total of 70 women were enrolled for this study. Sixty-eight 
clients returned for follow-up at 1 month and 67 were seen 
at the third contact, therefore, the response rate was 97% 
and 95% at 1 and 3 months, respectively. The mean age of 
the respondents with IUCD was 26.54 ± 2.1 years and that 
of the non-IUCD group was 26.30 ± 2.4 years. The age range 
was similar between the two groups which was 17–45 years. 
Eighteen (51.4%) of the respondents from each group were 
between 25 and 34 years of age.
The majority of the respondents were unemployed, 14 (40%) 
in the IUCD group and 25 (71.4%) in the control group were 
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homemakers. Only 1 (2.9%) of the respondents in the IUCD 
group was single, and all women in the control group were 
married. In the IUCD group, majority were the only wives 
of their husbands while 20 (56.1%) of the controls were in 
a polygamous family setting. Majority of the women were 
Muslims, 30 (85.7%) in the IUCD group and 34 (97.1%) in the 
control group. The respondents were mainly Hausa/Fulani, 
accounting for 24 (91.4%) in the IUCD group and 34 (97.1%) 
of the controls. Majority of the respondents were formally 
educated and only 3 (8.6%) in the IUCD group and 5 (14.2%) 
of the controls had no formal education. Most of the women 
had 1–5 previous deliveries and only 1 (1.4%) respondent was 
a nullipara [Table 1].
Of the 35 respondents who used IUCD, 24 (34.29%) used 
Copper T 380A and 11 (15.71%) used levonorgestrel 
intrauterine system containing IUCD. Thirty-five women 
used other forms of contraceptives during the same period. 
Twenty-six (37.14%) women used subdermal implants, 
5 (7.14%) used injectable contraceptives, and 4 (5.71%) used 
combined oral contraceptive pills [Figure 1].
Following insertion of IUCD, the incidence of genital infection 
was 3 (8.5%) at 1 and 4 (12.1%) at 3 months. The incidence 
in other contraceptive users was 2 (5.9%) at 1 month and 
3 (8.8%) at 3 months [Figure 2].
At 1 month, 34 women from each group came for follow-up. 
Three (8.5%) respondents among IUCD users had genital 
infection while 2 (5.9%) had genital infection in the 
non-IUCD group. Although more IUCD users had genital 
infection, the differences between the IUCD users and 
non-IUCD users was not statistically significant (χ2 = 0.654, 
P = 0.464). At 3 months, 33 women among IUCD users 
came for follow-up while 34 of the non-IUCD users 
returned for follow-up. Among the IUCD users, 4 (12.1%) 
had genital infection while 3 (8.8%) had genital infection 
among non-IUCD users. The observed difference among 
the two groups was not statistically significant (χ2 = 2.967, 
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Figure 2: Incidence of genital infection among intrauterine contraceptive 
device users compared to nonintrauterine contraceptive device users
Table 1: Sociodemographic characteristics of respondents
Characteristic Frequency (%)
IUCD users Non‑IUCD users
Occupation
Housewife 14 (40.0) 25 (71.4)
Civil servant 11 (31.4) 4 (11.4)
Trader 8 (22.9) 5 (14.3)
Others 2 (5.7) 1 (2.9)
Marital status
Single 1 (2.9) 0 (0)
Married 34 (97.1) 35 (100)
Husband’s number of wives
1 21 (60.0) 15 (42.9)
2 10 (28.6) 15 (42.9)
3 3 (8.6) 3 (8.6)
4 1 (2.9) 2 (5.7)
Religion
Islam 30 (85.7) 34 (97.1)
Christianity 5 (14.3) 1 (2.9)
Tribe
Hausa/Fulani 24 (68.6) 34 (97.1)
Igbo 1 (2.9) 1 (2.9)
Yoruba 3 (8.6) 0 (0)
Others 7 (20.0) 0 (0)
Educational status
No formal education 3 (8.6) 5 (14.9)
Primary 5 (14.9) 4 (11.3)
Secondary 11 (31.4) 17 (48.6)
Tertiary 16 (45.7) 9 (25.7)
Parity
0 1 (2.9) 0
1‑5 26 (74.3) 30 (85.7)
6‑10 8 (22.9) 5 (14.3)
IUCD ‑ Intrauterine contraceptive device
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The relative risk of IUCD causing genital infection was 
1.44 at 1 month and 1.5 at 3 months while the attributable 
risk at 1 month was 26/1000 and 40/1000 at 3 months. 
However, the observed difference in the rate of infection 
between IUCD users and other contraceptive users was not 
statistically significant.
In the IUCD group, 2 (5.8) women had Bacteria vaginosis 
at 1 month and 2 (6%) had it at 3 months while 1 (2.9) 
had T. vaginalis at 1 month and 2 (6%) at 3 months. In the 
non-IUCD group, 1 (2.9%) woman had T. vaginalis, Bacteria 
vaginosis at 1 month while 1 (2.9%) woman had T. vaginalis, 
Bacteria vaginosis, and Candida albican at 3 months. Only 
1 (3%) of the clients in the IUCD group had N. gonorrhoeae 
and it was at 3 months, but none had C. trachomatis. In 
the non-IUCD group, no participant had N. gonorrhoeae or 
T. vaginalis [Table 3].
Discussion
The incidence of genital infection among IUCD users was 
8.5% at 1 month and 12.1% at 3 months following insertion of 
the devices. In the non-IUCD users, the incidence of genital 
infection was 2 (5.9%) at 1 month and 3 (8.8%) at 3 months. The 
relative risk was 1.44 and 1.5 at 1 and 3 months, respectively, 
however, the difference was not significant.
Most studies determined incidence of only pelvic inflammatory 
infection and not genital infections generally, this may be due 
to the fact that PID is associated with serious morbidities. 
The incidence of pelvic inflammatory infections among 
intrauterine device users is between 0 and 2.1%. The higher 
incidence in our study is not unexpected as both upper and 
lower genital infections were considered.
Recent studies consistently revealed that relative risk of 
PID in IUCD users compared to women using no method 
to be 1.5–2.6.[5] This increase is only for a few months 
after insertion. The relative risk from a study by Buchan 
et al. was 3.3 for copper IUCD and 1.8 for hormonal IUCDs 
when compared to noncontraceptive users.[6] The difference 
between the three groups was not significant. Similarly, 
Beerthuizen also found a relative risk of 1.8 in clients with 
copper-containing IUCD compared to noncontraceptive 
users.[7] The separation of copper and hormonal IUCDs may 
have influenced the overall result, more so the comparison 
in these two studies were with noncontraceptive users. The 
studies also assessed women with only upper genital tract 
infection and did not consider lower genital infection.
In the WHO IUCD clinical trial data to explore the incidence 
and pattern of PID risk with the use of IUCD, the overall rate 
of PID among 22,908 IUCD insertions and during 51,399 
woman-years of follow-up was 1.6 cases/1000 woman-years 
of use.[8] Unlike in our study where genital infections 
were considered generally, only PID (upper genital tract 
infection) was considered in the WHO study. In a cohort 
study conducted in England, the incidence of acute of PID 
was 1.51/1000 woman-years while that of chronic PID was 
0.54 per 1000 woman-years.[9] Like in the WHO study, only 
upper genital infection was considered. Rydén et al. found 
the incidence of gonorrhea among IUCD users to be 23.5% 
and 8.8% among hormonal contraceptive users and 15.1% in 
women using neither technique.[10] There was no significant 
difference demonstrated. In the United States, the incidence 
of Bacteria vaginosis was 37% among IUCD users, and the 
incidence among oral contraceptive users was 19.3%.[11] This 
was also a cohort study, but the clients were followed for 
6 months. In addition, only Bacteria vaginosis was studied. 
Blum et al. found the incidence of C. trachomatis to be 16.7% 
in IUCD users, 38.6% among oral contraceptive users and 
21.1% in other contraceptive users.[12] Avonts et al. found the 
incidence of Chlamydia to be 0.8/100-woman years among 
IUCD users and 7/100-woman years for oral contraceptive 
users yielding a relative risk of 0.11.[13] In the same study, 
the incidence of Bacteria vaginosis was 25/100-woman 
years among IUCD users and 9/100-woman years in oral 
contraceptive users with a relative risk of 2.8.[13] Only Bacteria 
Table 2: Comparison of the association of genital infection 
between intrauterine contraceptive device and other 
contraceptive methods
Infection, frequency (%) Test of significance (χ2, P)
No Yes
1 month
IUCD 31 (91.5) 3 (8.5) 0.654, 0.464
Non‑IUCD 32 (94.1) 2 (5.9)
3 months
IUCD 29 (87.9) 4 (12.1) 2.967, 0.085
Non‑IUCD 31 (67.6) 3 (8.8)
IUCD ‑ Intrauterine contraceptive device
Table 3: Incidence of specific organisms among intrauterine 
contraceptive device users compared to nonintrauterine 
contraceptive device users









Neisseria gonorrhoea 0 0 1 (3) 0
Chlamydia trachomatis 0 0 0 0
Bacterial vaginosis 2 (5.8) 0 2 (6) 1 (2.9)
Trichomonas vaginalis 1 (2.9) 1 (2.9) 2 (6) 1 (2.9)
Candida albicans 0 0 1 (3) 1 (2.9)
Actinomycetes species 0 0 0 0
Others 1 (2.9) 1 (2.9) 1 (2.9) 0
IUCD ‑ Intrauterine contraceptive device
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vaginosis and chlamydia were considered in the study unlike 
the study conducted where some other organisms were 
considered.
T. vaginalis and G. vaginalis were the most common isolated 
organisms among IUCD users. They were also isolated in 
the non-IUCD group hence IUCD may not be responsible for 
higher incidence of T. vaginalis. A similar finding was made 
in Antakya, Turkey.[14] In contrast, Candida species were the 
commonest isolated organisms in Benin,[15] Sudan[16] and 
Trabzon, Turkey.[17] Bacteria vaginosis was the most prevalent 
genital infection among IUCD users in studies conducted 
in Brazil[18] and Iran.[19] However, in addition to T. vaginalis 
and Bacteria vaginosis, Candida was also common among 
IUCD users in Basra, Iraq.[20] These studies were prevalence 
studies, the infection status of the clients were not known 
before commencement of the various methods. The different 
organisms isolated in these studies may be a reflection of 
the pattern of genital infections in the general population 
of the study areas. Although studies evaluating microbes 
in non-IUCD contraceptives as a group are few, some have 
studied different contraceptive methods. In the study by 
Shobeiri et al.; Staph aureus was the most common organism 
among other contraceptive users.[19] Avonts et al. found that 
C. trachomatis was the most common isolated microbe among 
users of oral pills.[13] Sharief found G. vaginalis among users 
of oral pills.[20]
The incidence of genital infection among IUCD users was 
relatively low. IUCDs do not significantly increase the rate 
genital infection when compared with other contraceptive 
methods. T. vaginalis and G. vaginalis were isolated in both 
groups.
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